VISEN Pharma (VISEN Pharmaceuticals, incorporated in the Cayman Islands) published an updated list of directors and their roles, effective 27 August 2026. The Board now comprises one executive director, five non-executive directors, and three independent non-executive directors.

Executive leadership: • Executive Director – Lu An-Bang. • Chairman of the Board – Fu Shan, serving as a non-executive director.

Board committees: • Audit Committee: chaired by independent non-executive director Chan Peng Kuan, with independent non-executive director Zhang Qing and non-executive director Michael J. Chang as members. • Remuneration Committee: chaired by independent non-executive director Ni Hong, with Chan Peng Kuan and Zhang Qing as members. • Nomination Committee: chaired by Fu Shan, with Lu An-Bang as a member.

The announcement did not disclose any changes to financial guidance or operational strategy; the update is limited to board composition and committee responsibilities.